张振华,阚云珍,苏自杰.miR-139通过下调CXCR4/CXCL12生物轴抑制乳腺癌定向转移的分子机制研究[J].中国肿瘤,2018,27(1):61-67. |
miR-139通过下调CXCR4/CXCL12生物轴抑制乳腺癌定向转移的分子机制研究 |
Molecular Mechanism of MiR-139 Inhibiting Directional Metastasis of Breast Cancer by Down-regulating CXCR4-CXCL12 Bio-axis |
投稿时间:2017-04-07 |
DOI:10.11735/j.issn.1004-0242.2018.01.A009 |
|
 |
中文关键词: 乳腺癌 miRNA-139 CXCR4/CXCL12 定向转移 |
英文关键词:beast cancer miRNA-139 CXCR4/CXCL12 directed metastasis |
基金项目:2013年河南省重点科技攻关计划项目(132102310095) |
|
摘要点击次数: 2519 |
全文下载次数: 786 |
中文摘要: |
摘 要:[目的] 检测miR-139在乳腺癌细胞系及组织中的表达,验证CXCR4是否为miR-139直接调控的靶基因,并探究miR-139是否可通过靶向抑制CXCR4/CXCL12生物轴从而抑制乳腺癌细胞的定向转移。[方法] 实时荧光定量聚合酶链式反应(qRT-PCR)用于检测miR-139在34对转移性乳腺癌患者的原发灶、转移灶及癌旁组织中,在5株乳腺癌细胞系及1株正常乳腺上皮细胞中的表达。将包含miR-139的重组慢病毒质粒及其阴性对照空载体质粒vector分别以病毒/细胞数量=20的比例感染MDA-MB-231细胞,经2.0μg/ml嘌呤霉素筛选,成功构建稳定表达miR-139或vector的MDA-MB-231细胞,将MDA-MB-231vector和MDA-MB-231miR-139细胞分别经尾静脉注射到BALB/c裸鼠中,构建乳腺癌裸鼠转移模型,观察过表达miR-139对裸鼠体内转移能力的影响。TargetScan软件用于预测miR-139的靶基因,根据预测结果,将野生型或突变型CXCR4的3’-UTR区域克隆到荧光素酶报告基因的下游(CXCR4-wt或CXCR4-mut)并分别与miR-139 mimics或scramble共转染后检测荧光素酶的活性。qRT-PCR和Western blot分别检测转染miR-139 mimics和scramble后CXCR4、CXCL12的mRNA和蛋白表达。[结果] miR-139在转移性乳腺癌原发灶和转移灶中的表达均低于癌旁组织,且转移灶中表达最低,miR-139在乳腺癌细胞系中的表达水平显著低于正常乳腺上皮细胞MCF-10A,且MDA-MB-231细胞中最低。尾静脉注射MDA-MB-231miR-139的裸鼠肺转移灶的个数均显著低于MDA-MB-231vector细胞。TargetScan软件预测CXCR4为miR-139直接调控的靶基因,CXCR4-wt+miR-139共转染组比CXCR4-wt+scramble共转染组的荧光素酶活性强度显著降低,CXCR4-mut+miR-139共转染组和CXCR4-wt+scramble共转染组间荧光素酶活性强度无显著性差异。转染miR-139后,CXCR4和CXCL12的mRNA和蛋白表达水平均显著下调,CXCR4/CXCL12生物轴下游的p-AKT和p-ERK蛋白表达水平也显著下调。[结论] miR-139可通过靶向调控CXCR4/CXCL12生物轴而抑制乳腺癌细胞MDA-MB-231定向转移。 |
英文摘要: |
Abstract:[Purpose]To investigate the effect of miR-139 on directional metastasis of breast cancer (BC) and related molecular mechanism. [Methods] qRT-PCR was used to detect the expression of miR-139 in the primary,metastatic cancer and adjacent tissues of 34 patients with metastatic breast cancer and 5 breast cancer cell lines and 1 normal mammary epithelial cell line MCF-10A. Breast cancer MDA-MB-231 cells were infected with recombinant lentivirus plasmid containing miR-139 and its negative control vector to construct stable MDA-MB-231miR-139 and MDA-MB-231vector cells. The two stable cells were injected into BALB/c nude mice via tail vein to construct metastatic model of breast cancer,respectively. And the effect of miR-139 expression on metastasis in nude mice was observed. TargetScan was used to predict the target gene of miR-139,and the 3′-UTR region of wild-type or mutant CXCR4 was cloned into downstream of the luciferase reporter gene(CXCR4-wt or CXCR4-mut) and tested for luciferase activity after co-transfection into MDA-MB-231 cells with miR-139 mimics or scramble. MDA-MB-231 cells were transfected with miR-139 mimics and scramble,the mRNA and protein expressions of CXCR4 and CXCL12 were detected by qRT-PCR and Western blot methods. [Results] The expression of miR-139 was lower in primary and metastatic lesions than that in adjacent tissues,and lowest in metastatic lesions.The expression of miR-139 in breast cancer cell lines was significantly lower than that in normal mammary epithelial MCF-10A cells,and lowest in MDA-MB-231 cells. The number of metastatic foci formed by MDA-MB-231miR-139 in nude mice were significantly lower than that of MDA-MB-231vector cells. TargetScan predicted that CXCR4 was the direct target of miR-139. miR-139 significantly suppressed the luciferase activity in CXCR4-wt+miR-139 co-transfection group than CXCR4-wt+scramble group. There was no significant difference in luciferase activity between CXCR4-mut+miR-139 and CXCR4-wt+scramble co-transfection group. The mRNA and protein expression levels of CXCR4 and CXCL12 were significantly reduced in MDA-MB-231 cells after transfection of miR-139,the expression levels of p-AKT and p-ERK proteins,which were the downstream of CXCR4/CXCL12 bio-axis,were also significantly down-regulated after transfection of miR-139. [Conclusion] MiR-139 can inhibit the directional metastasis of breast cancer MDA-MB-231 cells by targeting CXCR4/CXCL12 bio-axis. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |